Trials / Withdrawn
WithdrawnNCT05945160
Vestibular Function Using Mitochondrial Antioxidant Therapy
A Randomized Controlled Study Using Alpha Lipoic Acid and CoQ-10 to Determine if Vestibular Function Can be Improved or Maintained Over the Course of One Year
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 65 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
To determine if supplementation with known mitochondrial antioxidants (alpha lipoic acid (ALA) and CoQ-10) will stabilize or improve vestibular function in older adults.
Detailed description
The subjects will be divided into two groups, half will be given daily supplementation with ALA and CoQ-10. The second group will only receive standard of care treatment, with no study drug intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alpha Lipoic Acid 300mg | A naturally occuring mitochondrial antioxidant |
| DRUG | Coenzyme Q10 200mg | A naturally occuring mitochondrial antioxidant |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-08-01
- Completion
- 2024-12-01
- First posted
- 2023-07-14
- Last updated
- 2023-10-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05945160. Inclusion in this directory is not an endorsement.